BrahMos WORLD INDIA MADHYA PRADESH BHOPAL WTN SPECIAL GOSSIP CORNER RELIGION SPORTS BUSINESS FUN FACTS ENTERTAINMENT LIFESTYLE TRAVEL ART & LITERATURE SCIENCE & TECHNOLOGY HEALTH EDUCATION DIASPORA OPINION & INTERVIEW RECIPES DRINKS BIG MEMSAAB 2017 BUDGET 2017 FUNNY VIDEOS VIRAL ON WEB PICTURE STORIES Mahakal Ke Darshan
WTN HINDI ABOUT US PRIVACY POLICY SITEMAP CONTACT US
N
W
T
logo
Breaking News

Cannabis extract may offer treatment for psychosis: Study

Thursday - August 30, 2018 7:02 pm , Category : DIASPORA
London Aug 30 (IANS) A single dose of the non-intoxicating compound of cannabis -- cannabidiol -- can help reduce brain function abnormalities seen in people with psychosis results of a clinical trial led by an Indian-origin doctor has revealed.
Psychosis is a mental disorder characterised by a disconnection from reality. Brain activity in the people at risk of psychosis remains abnormal compared to the healthy ones. But in people who had cannabidiol the abnormal brain activity was less severe than for those who received a placebo suggesting cannabidiol can help re-adjust brain activity to normal levels. The results suggest that cannabidiol may normalise dysfunction in striatum parahippocampal cortex and midbrain -- brain regions which are critically implicated in psychosis -- and this may underlie its therapeutic effects in psychosis the researchers explained. "Our results have started unravelling the brain mechanisms of a new drug that works in a completely different way to traditional anti-psychotics " said Sagnik Bhattacharyya from Britain s King s College London. For the study published in JAMA Psychiatry the team studied a small group of young people who had not yet been diagnosed with psychosis but who were experiencing distressing psychotic symptoms along with healthy controls. All participants were studied in an MRI scanner while performing a memory task which engages three regions of the brain known to be involved in psychosis. "One of the main advantages of cannabidiol is that it is safe and seems to be very well tolerated making it in some ways an ideal treatment " Bhattacharyya said. "If successful this trial will provide definitive proof of cannabidiol s role as an antipsychotic treatment and pave the way for use in clinic " he noted.
--IANS rt/mag/sed